Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth Alper

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Frontiers in Medicine|January 11, 2021
Case Report: Famotidine for Neuropsychiatric Symptoms in COVID-19Kenneth Alper
The American Journal of Drug and Alcohol Abuse|May 26, 2017
Treatment of opioid use disorder with ibogaine: detoxification and drug use outcomesThomas Kingsley Brown, Kenneth Alper
Journal of Ethnopharmacology|December 28, 2011
Ibogaine and the inhibition of acetylcholinesteraseKenneth Alper, Maarten E A Reith, Henry Sershen
Biological Psychiatry|January 16, 2007
Seizure incidence in psychopharmacological clinical trials: an analysis of Food and Drug Administration (FDA) summary basis of approval reportsKenneth Alper, Kelly A Schwartz, Russell L Kolts, et al.
Frontiers in Pharmacology|September 21, 2018
LSD Administered as a Single Dose Reduces Alcohol Consumption in C57BL/6J MiceKenneth Alper, Bin Dong, Relish Shah, et al.
Journal of Neuroinflammation|April 4, 2013
Neuroinflammation and psychiatric illnessSouhel Najjar, Daniel M Pearlman, Kenneth Alper, et al.
Annals of the New York Academy of Sciences|July 10, 2002
Adaptation to repeated cocaine administration in ratsZbigniew K Binienda, Frederico Pereira, Kenneth Alper, et al.
Psychiatry Research|May 23, 2013
Childhood abuse and EEG source localization in crack cocaine dependenceKenneth Alper, Jaini Shah, Bryant Howard, et al.
Epilepsy & Behavior : E&B|July 17, 2004
Obsessive-compulsive symptoms in patients with temporal lobe epilepsyKeren L Isaacs, John W Philbeck, William B Barr, et al.
Frontiers in Pharmacology|January 23, 2023
Psilocybin sex-dependently reduces alcohol consumption in C57BL/6J miceKenneth Alper, Janelle Cange, Ria Sah, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Frontiers in Medicine|January 11, 2021
Case Report: Famotidine for Neuropsychiatric Symptoms in COVID-19Kenneth Alper
The American Journal of Drug and Alcohol Abuse|May 26, 2017
Treatment of opioid use disorder with ibogaine: detoxification and drug use outcomesThomas Kingsley Brown, Kenneth Alper
Journal of Ethnopharmacology|December 28, 2011
Ibogaine and the inhibition of acetylcholinesteraseKenneth Alper, Maarten E A Reith, Henry Sershen
Biological Psychiatry|January 16, 2007
Seizure incidence in psychopharmacological clinical trials: an analysis of Food and Drug Administration (FDA) summary basis of approval reportsKenneth Alper, Kelly A Schwartz, Russell L Kolts, et al.
Frontiers in Pharmacology|September 21, 2018
LSD Administered as a Single Dose Reduces Alcohol Consumption in C57BL/6J MiceKenneth Alper, Bin Dong, Relish Shah, et al.
Journal of Neuroinflammation|April 4, 2013
Neuroinflammation and psychiatric illnessSouhel Najjar, Daniel M Pearlman, Kenneth Alper, et al.
Annals of the New York Academy of Sciences|July 10, 2002
Adaptation to repeated cocaine administration in ratsZbigniew K Binienda, Frederico Pereira, Kenneth Alper, et al.
Psychiatry Research|May 23, 2013
Childhood abuse and EEG source localization in crack cocaine dependenceKenneth Alper, Jaini Shah, Bryant Howard, et al.
Epilepsy & Behavior : E&B|July 17, 2004
Obsessive-compulsive symptoms in patients with temporal lobe epilepsyKeren L Isaacs, John W Philbeck, William B Barr, et al.
Frontiers in Pharmacology|January 23, 2023
Psilocybin sex-dependently reduces alcohol consumption in C57BL/6J miceKenneth Alper, Janelle Cange, Ria Sah, et al.
Pageof 2